AZD8683

DRUG5 trials

Sponsors

AstraZeneca

Conditions

COPDChronic Obstructive Pulmonary DiseaseHealthyHealthy Volunteers

Phase 1

AZD8683 Single Ascending Dose Study

CompletedNCT00979849

AstraZenecaHealthy Volunteers

Start: 2009-10-31End: 2010-01-31Updated: 2010-03-02

To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of Inhaled AZD8683

CompletedNCT01419600

AstraZenecaHealthy

Start: 2011-10-31End: 2012-05-31Updated: 2012-07-03

AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

TerminatedNCT01584739

AstraZenecaCOPD

Start: 2012-06-30End: 2012-11-30Updated: 2012-12-03

A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD8683 When Administered in Different Ways

WithdrawnNCT01666613

AstraZenecaHealthy

Start: 2012-11-30End: 2013-03-31Updated: 2012-12-19

Phase 2

A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients

TerminatedNCT01708057

AstraZenecaChronic Obstructive Pulmonary Disease, COPD

Start: 2012-10-31End: 2012-12-31Updated: 2014-01-15